Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia

BMC Research Notes

Kevin G Greene²  Karen Weck²  Stacey O’Neill²  Nicholas J Shaheen¹  Dimitri G Trembath² 

[1] Department of Medicine and Epidemiology, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA;Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA

关键词: BRAF;    Melanoma;    Metastases;    Esophagus;    Barrett;   

Others  :  1140869
DOI  :  10.1186/1756-0500-6-457

 received in 2012-12-12, accepted in 2013-10-18,  发布年份 2013

【 摘 要 】

Background

Metastatic melanoma involving the esophagus is rare; the occurrence of metastatic melanoma in a background of Barrett esophagus is rarer still. We report a case of an 80 year-old male who presented to our institution for workup of Barrett esophagus with high-grade dysplasia and who proved to have metastatic melanoma occurring in the background of Barrett esophagus, the first report of this kind, to our knowledge, in the English literature.

Case presentation

An 80 year-old Caucasian male was diagnosed at an outside institution with Barrett’s esophagus with high grade dysplasia and presented to our institution for therapy. The patient underwent endoscopic mucosal resection using a band ligation technique of an area of nodularity within the Barrett esophagus. Microscopic examination demonstrated extensive Barrett esophagus with high-grade dysplasia as well as a second tumor which was morphologically different from the surrounding high-grade dysplasia and which was positive for S-100, HMB 45 and Melan-A on immunohistochemistry, consistent with melanoma. Further workup of the patient demonstrated multiple radiologic lesions consistent with metastases. Molecular studies demonstrated that the melanoma was positive for the 1799T>A (V600E) mutation in the BRAF gene. The overall features of the tumor were most consistent with metastatic melanoma occurring in a background of Barrett esophagus with high-grade dysplasia.

Conclusion

This case demonstrates a unique intersection between a premalignant condition (Barrett esophagus with high grade dysplasia) and a separate malignancy (melanoma). This report also shows the utility of molecular testing to support the hypothesis of primary versus metastatic disease in melanoma.

【 授权许可】

   
2013 Trembath et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Bisceglia M, Perri F, Tucci A, Tardio M, Panniello G, Vita G, Pasquinelli G: Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review. Adv Anat Pathol 2011, 18(3):235-252.
• [2]Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang H: Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med 2008, 132(10):1623-1629.
• [3]Voltaggio L, Montgomery EA, Lam-Himlin D: A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia. Arch Pathol Lab Med 2011, 135(10):1249-1260.
• [4]Shaheen NJ, Richter JE: Barrett's oesophagus. Lancet 2009, 373(9666):850-861.
• [5]Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P: Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008, 67(3):394-398.
• [6]De La Pava S, Nigogosyan G, Pickren JW, Cabrera A: Melanosis of the esophagus. Cancer 1963, 16:48-50.
• [7]Garfinkle JM, Cahan WG: Primary melanocarcinoma of the esophagus; fist histologically proved case. Cancer 1952, 5(5):921-926.
• [8]Pruyt M, Devriendt D, Vanneste A: Malignant melanoma and adenocarcinoma of a Barrett oesophagus. Acta Chir Belg 2006, 106(5):616-618.
• [9]Allan NK, Weitzner S, Scott L, Khalil KG: Adenocarcinoma arising in Barrett's esophagus with synchronous squamous cell carcinoma of the esophagus. South Med J 1986, 79(8):1036-1039.
• [10]Bibeau F, Chateau MC, Guiu M, Assenat E, Azria D, Lavaill R, Ychou M, Boissiere-Michot F: Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour. Virchows Arch 2008, 452(1):103-107.
• [11]Saw EC, Yu GS, Wagner G, Heng Y: Synchronous primary neuroendocrine carcinoma and adenocarcinoma in Barrett's esophagus. J Clin Gastroenterol 1997, 24(2):116-119.
• [12]Cuesta-Mejias T, de Leon-Bojorge B, Arias-Gutierrez A, Decanini-Teran C, Shueke-Esses M: Primary melanoma of the esophagus. Unusual case with Barrett's esophagus. Rev Gastroenterol Mex 2001, 66(3):146-149.
• [13]Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, et al.: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353(20):2135-2147.
• [14]Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al.: Mutations of the BRAF gene in human cancer. Nature 2002, 417(6892):949-954.
• [15]Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H, et al.: Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010, 468(7326):973-977.